MTHFR encodes methylenetetrahydrofolate reductase, a key enzyme in folate and homocysteine metabolism. During menopause, declining estrogen levels can affect homocysteine – a risk factor for cardiovascular disease and possibly osteoporosis. Certain MTHFR variants (e.g., C677T) reduce enzyme activity and, combined with low folate or B12, may raise homocysteine. However, evidence is moderate: many studies show associations, but no causal, clinically actionable prediction for individual menopause trajectory. A DNA test alone is insufficient; measuring blood homocysteine, folate, and B12 is more informative. Adequate B-vitamin intake (diet or supplements) may help, but should be discussed with a physician. Menopause is multifactorial; MTHFR is only one small piece.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-be2f82a6bee26021c77b70df